Download PDF
Psychiatrie und Psychotherapie up2date 2010; 4(02): 121-130
DOI: 10.1055/s-0029-1223481
Störungsübergreifende Themen und Methoden

Entwicklungen in der Neurogenetik am Beispiel der Schizophrenie

Andreas Meyer-Lindenberg
› Further Information
    Permissions and Reprints All articles of this category
Kernaussagen

  • Die psychiatrische Forschung hat auf dem Gebiet der Genetik rasante Fortschritte gemacht.

  • Methodische Neuentwicklungen haben zur Identifikation einer Reihe häufiger und seltener genetischer Risikofaktoren geführt und damit zur Klärung der Ätiologie dieser Erkrankungen wesentlich beigetragen.

  • Potenziell der größte Gewinn, den die praktische Psychiatrie aus der genetisch-neurogenetischen Grundlagenforschung ziehen kann, sind Ansätze, Gene zum Ausgangspunkt einer translationalen Forschung zu machen, die zur Entwicklung mechanistisch neuer Therapieverfahren führt. Die geschilderten ersten Ansatzpunkte hierfür sind erfolgversprechend und geben Anlass zur Hoffnung, mithilfe gesicherter genetischer Daten schwere psychiatrische Erkrankungen finden zu können.



Publication History

Publication Date:
01 March 2010 (online)

© Georg Thieme Verlag KG Stuttgart · New York

 

  • Literatur

  • Sullivan PF, Kendler KS, Neale MC. Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies.. Arch Gen Psychiatry 2003; 60: 1187-1192
    CrossrefPubMedGoogle Scholar
  • Sullivan PF, Neale MC, Kendler KS. Genetic epidemiology of major depression: review and meta-analysis.. Am J Psychiatry 2000; 157: 1552-1562
    CrossrefPubMedGoogle Scholar
  • McPherson JD, Marra M, Hillier L. et al. A physical map of the human genome.. Nature 2001; 409: 934-941
    CrossrefPubMedGoogle Scholar
  • International Hapmap Consortium. A haplotype map of the human genome.. Nature 2005; 437: 1299-1320
    CrossrefPubMedGoogle Scholar
  • Manolio TA, Brooks LD, Collins FS. A HapMap harvest of insights into the genetics of common disease.. The Journal of clinical investigation 2008; 118: 1590-1605
    CrossrefPubMedGoogle Scholar
  • O'Donovan MC, Craddock NJ, Owen MJ. Genetics of psychosis; insights from views across the genome.. Hum Genet 2009; 126: 3-12
    CrossrefPubMedGoogle Scholar
  • Purcell SM, Wray NR, Stone JL. et al. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder.. Nature 2009; 460: 748-752
    CrossrefPubMedGoogle Scholar
  • Shi J, Levinson DF, Duan J. et al. Common variants on chromosome 6p22.1 are associated with schizophrenia.. Nature 2009; 460: 753-757
    CrossrefPubMedGoogle Scholar
  • Stefansson H, Ophoff RA, Steinberg S. et al. Common variants conferring risk of schizophrenia.. Nature 2009; 460: 744-747
    CrossrefPubMedGoogle Scholar
  • O'Donovan MC, Craddock N, Norton N. et al. Identification of loci associated with schizophrenia by genome-wide association and follow-up.. Nat Genet 2008; 40: 1053-1055
    CrossrefPubMedGoogle Scholar
  • Esslinger C, Walter H, Kirsch P. et al. Neural mechanisms of a genome-wide supported psychosis variant.. Science 2009; 324: 605
    CrossrefPubMedGoogle Scholar
  • Meyer-Lindenberg AS, Olsen RK, Kohn PD. et al. Regionally specific disturbance of dorsolateral prefrontal-hippocampal functional connectivity in schizophrenia.. Arch Gen Psychiatry 2005; 62: 379-386
    CrossrefPubMedGoogle Scholar
  • Redon R, Ishikawa S, Fitch KR. et al. Global variation in copy number in the human genome.. Nature 2006; 444: 444-454
    CrossrefPubMedGoogle Scholar
  • Stefansson H, Rujescu D, Cichon S. et al. Large recurrent microdeletions associated with schizophrenia.. Nature 2008; 455: 232-236
    CrossrefPubMedGoogle Scholar
  • Walsh T, McClellan JM, McCarthy SE. et al. Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia.. Science 2008; 320: 539-543
    CrossrefPubMedGoogle Scholar
  • International SchizophreniaConsortium” IS. Rare chromosomal deletions and duplications increase risk of schizophrenia.. Nature 2008; 455: 237-241
    CrossrefPubMedGoogle Scholar
  • Insel TR, Scolnick EM. Cure therapeutics and strategic prevention: raising the bar for mental health research.. Mol Psychiatry 2006; 11: 11-17
    CrossrefPubMedGoogle Scholar
  • Meyer-Lindenberg A, Kohn PD, Kolachana B. et al. Midbrain dopamine and prefrontal function in humans: interaction and modulation by COMT genotype.. Nat Neurosci 2005; 8: 594-596
    CrossrefPubMedGoogle Scholar
  • Apud JA, Mattay V, Chen J. et al. Tolcapone improves cognition and cortical information processing in normal human subjects.. Neuropsychopharmacology 2007; 32: 1011-1020
    CrossrefPubMedGoogle Scholar
  • Meyer-Lindenberg A, Weinberger DR. Intermediate phenotypes and genetic mechanisms of psychiatric disorders.. Nat Rev Neurosci 2006; 7: 818-827
    CrossrefPubMedGoogle Scholar
  • Huffaker SJ, Chen J, Nicodemus KK. et al. A primate-specific, brain isoform of KCNH2 affects cortical physiology, cognition, neuronal repolarization and risk of schizophrenia.. Nat Med 2009; 15: 509-518
    CrossrefPubMedGoogle Scholar
  • Patil ST, Zhang L, Martenyi F. et al. Activation of mGlu2 / 3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial.. Nat Med 2007; 13: 1102-1107
    CrossrefPubMedGoogle Scholar
  • Tan HY, Chen Q, Sust S. et al. Epistasis between catechol-O-methyltransferase and type II metabotropic glutamate receptor 3 genes on working memory brain function.. Proc Natl Acad Sci U S A 2007; 104: 12536-12541
    CrossrefPubMedGoogle Scholar